1. Home
  2. LCTX
  3. LCTX News

Latest Lineage Cell Therapeutics Inc. (LCTX) News on November 18, 2025

Dry Age-related Macular Degeneration Market Poised for Rapid Growth During the Forecast Period (2025–2034) Amid Expanding Treatment Landscape | DelveInsight
LCTX

GlobeNewswire

a day ago

Dry Age-related Macular Degeneration Market Poised for Rapid Growth During the Forecast Period (2025–2034) Amid Expanding Treatment Landscape | DelveInsight

Lineage Cell Therapeutics Inc (LCTX) Q3 2025 Earnings Call Highlights: Strategic Partnerships ...
LCTX

GuruFocus.com

12 days ago

Lineage Cell Therapeutics Inc (LCTX) Q3 2025 Earnings Call Highlights: Strategic Partnerships ...

Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates
LCTX

Zacks

12 days ago

Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates

LCTX

Associated Press Finance

12 days ago

Lineage Cell: Q3 Earnings Snapshot

Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
LCTX

Business Wire

12 days ago

Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Lineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025
LCTX

Business Wire

19 days ago

Lineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025

Strength Seen in Wave Life Sciences (WVE): Can Its 11.4% Jump Turn into More Strength?
LCTX

Zacks

a month ago

Strength Seen in Wave Life Sciences (WVE): Can Its 11.4% Jump Turn into More Strength?

LCTX

MT Newswires

5 months ago

Sector Update: Health Care Stocks Mixed Late Afternoon

LCTX

MT Newswires

5 months ago

Sector Update: Health Care

LCTX

MT Newswires

5 months ago

Lineage Cell Therapeutics Phase 1/2a Trial of OpRegen Shows Consistent Visual Acuity Improvement

OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025
LCTX

Business Wire

5 months ago

OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025

Lineage Cell Therapeutics Announces Updates to the 3rd Annual Spinal Cord Injury Investor Symposium
LCTX

Business Wire

5 months ago

Lineage Cell Therapeutics Announces Updates to the 3rd Annual Spinal Cord Injury Investor Symposium

LCTX

Thomson Reuters StreetEvents

6 months ago

Q1 2025 Lineage Cell Therapeutics Inc Earnings Call

Lineage to Present at 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC
LCTX

Business Wire

6 months ago

Lineage to Present at 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC

Lineage Cell Therapeutics Inc (LCTX) Q1 2025 Earnings Call Highlights: Strategic Advances and ...
LCTX

GuruFocus.com

6 months ago

Lineage Cell Therapeutics Inc (LCTX) Q1 2025 Earnings Call Highlights: Strategic Advances and ...

Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates
LCTX

Zacks

6 months ago

Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates

Lineage Cell Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
LCTX

Business Wire

6 months ago

Lineage Cell Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Editas Medicine (EDIT) Reports Q1 Loss, Tops Revenue Estimates
LCTX

Zacks

6 months ago

Editas Medicine (EDIT) Reports Q1 Loss, Tops Revenue Estimates

RG6501 (OpRegen®) Phase 1/2a Clinical Study 36 Month Results to Be Featured at Clinical Trials at the Summit 2025
LCTX

Business Wire

6 months ago

RG6501 (OpRegen®) Phase 1/2a Clinical Study 36 Month Results to Be Featured at Clinical Trials at the Summit 2025

Lineage Cell Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025
LCTX

Business Wire

7 months ago

Lineage Cell Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025

Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 3rd Annual Spinal Cord Injury Investor Symposium
LCTX

Business Wire

7 months ago

Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 3rd Annual Spinal Cord Injury Investor Symposium

Lineage to Present at 2025 Eyecelerator Meeting Sponsored by the American Academy of Ophthalmology (AAO)
LCTX

Business Wire

7 months ago

Lineage to Present at 2025 Eyecelerator Meeting Sponsored by the American Academy of Ophthalmology (AAO)

LCTX

MT Newswires

8 months ago

B. Riley Cuts Price Target on Lineage Cell Therapeutics to $3 From $4, Keeps Buy Rating

LCTX

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Lineage Cell Therapeutics Inc Earnings Call

Lineage Cell Therapeutics Inc (LCTX) Q4 2024 Earnings Call Highlights: Strategic Advances and ...
LCTX

GuruFocus.com

8 months ago

Lineage Cell Therapeutics Inc (LCTX) Q4 2024 Earnings Call Highlights: Strategic Advances and ...

Lineage Cell (LCTX) Reports Q4 Loss, Tops Revenue Estimates
LCTX

Zacks

8 months ago

Lineage Cell (LCTX) Reports Q4 Loss, Tops Revenue Estimates

Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
LCTX

Business Wire

8 months ago

Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Zymeworks Inc. (ZYME) Reports Q4 Loss, Misses Revenue Estimates
LCTX

Zacks

8 months ago

Zymeworks Inc. (ZYME) Reports Q4 Loss, Misses Revenue Estimates

Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on March 10, 2025
LCTX

Business Wire

8 months ago

Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on March 10, 2025

Lineage begins study of OPC1 delivering device for spinal cord injury treatment
LCTX

Medical Device Network

9 months ago

Lineage begins study of OPC1 delivering device for spinal cord injury treatment

LCTX

MT Newswires

9 months ago

Lineage Cell Therapeutics Begins Stem Cell Therapy Trial for Spinal Cord Injury

Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury
LCTX

Business Wire

9 months ago

Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury

Lineage Cell Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Lifesciences Conference
LCTX

Business Wire

9 months ago

Lineage Cell Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Lifesciences Conference

Lineage Cell (LCTX) Upgraded to Strong Buy: What Does It Mean for the Stock?
LCTX

Zacks

10 months ago

Lineage Cell (LCTX) Upgraded to Strong Buy: What Does It Mean for the Stock?

Lineage Cell Therapeutics Announces Closing of Second Tranche of Previously Announced Registered Direct Offering
LCTX

Business Wire

10 months ago

Lineage Cell Therapeutics Announces Closing of Second Tranche of Previously Announced Registered Direct Offering

Lineage Cell Therapeutics Issues Letter to Stockholders
LCTX

Business Wire

10 months ago

Lineage Cell Therapeutics Issues Letter to Stockholders

Lineage Cell price target lowered to $2 from $3 at D. Boral Capital
LCTX

TipRanks

10 months ago

Lineage Cell price target lowered to $2 from $3 at D. Boral Capital

Down -43.14% in 4 Weeks, Here's Why Lineage Cell (LCTX) Looks Ripe for a Turnaround
LCTX

Zacks

a year ago

Down -43.14% in 4 Weeks, Here's Why Lineage Cell (LCTX) Looks Ripe for a Turnaround

Is Lineage (LINE) the Best New Pick in Brad Gerstner’s Portfolio?
LCTX

Insider Monkey

a year ago

Is Lineage (LINE) the Best New Pick in Brad Gerstner’s Portfolio?

Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering
LCTX

Business Wire

a year ago

Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering

Lineage Cell (LCTX) Loses -26.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
LCTX

Zacks

a year ago

Lineage Cell (LCTX) Loses -26.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering
LCTX

Business Wire

a year ago

Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering

Lineage Cell Therapeutics Inc (LCTX) Q3 2024 Earnings Call Highlights: Strategic Advances and ...
LCTX

GuruFocus.com

a year ago

Lineage Cell Therapeutics Inc (LCTX) Q3 2024 Earnings Call Highlights: Strategic Advances and ...

Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates
LCTX

Zacks

a year ago

Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates

Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
LCTX

Business Wire

a year ago

Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Tops Revenue Estimates
LCTX

Zacks

a year ago

MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Tops Revenue Estimates

Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates
LCTX

Zacks

a year ago

Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates

Lineage Cell Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on November 14, 2024
LCTX

Business Wire

a year ago

Lineage Cell Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on November 14, 2024

NovoCure (NVCR) Surges 10.7%: Is This an Indication of Further Gains?
LCTX

Zacks

a year ago

NovoCure (NVCR) Surges 10.7%: Is This an Indication of Further Gains?

Lineage Cell Therapeutics to Present at the Maxim Group 2024 Virtual Healthcare Summit
LCTX

Business Wire

a year ago

Lineage Cell Therapeutics to Present at the Maxim Group 2024 Virtual Healthcare Summit

Lineage Cell Therapeutics Inc (LCTX) Q2 2024 Earnings Call Highlights: Strategic Alliances and ...
LCTX

GuruFocus.com

a year ago

Lineage Cell Therapeutics Inc (LCTX) Q2 2024 Earnings Call Highlights: Strategic Alliances and ...

What Makes Lineage Cell (LCTX) a New Buy Stock
LCTX

Zacks

a year ago

What Makes Lineage Cell (LCTX) a New Buy Stock

OpRegen® (RG6501) Phase 1/2a Results to Be Featured at International Society for Stem Cell Research (ISSCR) 2024 Copenhagen International Symposium
LCTX

Business Wire

a year ago

OpRegen® (RG6501) Phase 1/2a Results to Be Featured at International Society for Stem Cell Research (ISSCR) 2024 Copenhagen International Symposium

Lineage Presents Preclinical Data on Its Auditory Neuronal Cell Transplant Program, ReSonance™, at the 59th Annual Inner Ear Biology Workshop
LCTX

Business Wire

a year ago

Lineage Presents Preclinical Data on Its Auditory Neuronal Cell Transplant Program, ReSonance™, at the 59th Annual Inner Ear Biology Workshop

LCTX

MT Newswires

a year ago

Craig-Hallum Initiates Lineage Cell Therapeutics at Buy With $4 Price Target

Lineage Cell Therapeutics to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
LCTX

Business Wire

a year ago

Lineage Cell Therapeutics to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

Lineage Cell (LCTX) Reports Q2 Loss, Tops Revenue Estimates
LCTX

Zacks

a year ago

Lineage Cell (LCTX) Reports Q2 Loss, Tops Revenue Estimates

Lineage Cell Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
LCTX

Business Wire

a year ago

Lineage Cell Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Misses Revenue Estimates
LCTX

Zacks

a year ago

Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Misses Revenue Estimates

Lineage Cell Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
LCTX

Business Wire

a year ago

Lineage Cell Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024

LCTX

MT Newswires

a year ago

Lineage Cell Therapeutics Included in Russell 3000 Index

Lineage Cell Therapeutics Added to Membership of 2024 Russell 3000® Index
LCTX

Business Wire

a year ago

Lineage Cell Therapeutics Added to Membership of 2024 Russell 3000® Index

Italian energy company targets Britain for fleet of 20 mini-nukes
LCTX

The Telegraph

a year ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
LCTX

Motley Fool

a year ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North
LCTX

AFP

a year ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss
LCTX

Simply Wall St.

a year ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations
LCTX

Simply Wall St.

a year ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns
LCTX

Simply Wall St.

a year ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
LCTX

Simply Wall St.

a year ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled
LCTX

Motley Fool

a year ago

3 Mistakes That Can Get Your Costco Membership Canceled

Lineage to Present at 2024 BIO International Convention
LCTX

Business Wire

a year ago

Lineage to Present at 2024 BIO International Convention

Lineage Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium
LCTX

Business Wire

a year ago

Lineage Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2024 Earnings Call Transcript
LCTX

Insider Monkey

2 years ago

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2024 Earnings Call Transcript

LCTX

GuruFocus.com

2 years ago

Lineage Cell Therapeutics Q1 2024 Earnings: Aligns with EPS Projections Amidst Revenue Declines

LCTX

Thomson Reuters StreetEvents

2 years ago

Q1 2024 Lineage Cell Therapeutics Inc Earnings Call

Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
LCTX

Business Wire

2 years ago

Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
LCTX

Business Wire

2 years ago

OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit

Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024
LCTX

Business Wire

2 years ago

Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024

Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)
LCTX

Business Wire

2 years ago

Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)

Lineage Announces Changes to Board of Directors
LCTX

Business Wire

2 years ago

Lineage Announces Changes to Board of Directors

12 Cheap Foods With Anti-Aging Properties That Longevity Scientists Swear By
LCTX

Insider Monkey

2 years ago

12 Cheap Foods With Anti-Aging Properties That Longevity Scientists Swear By

Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development
LCTX

Business Wire

2 years ago

Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development

15 Best Anti-Aging Foods for Youthful Skin
LCTX

Insider Monkey

2 years ago

15 Best Anti-Aging Foods for Youthful Skin

Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium
LCTX

Business Wire

2 years ago

Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium

Billionaire Ken Fisher and Corporate Insiders Are Buying These 10 Stocks
LCTX

Insider Monkey

2 years ago

Billionaire Ken Fisher and Corporate Insiders Are Buying These 10 Stocks

RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
LCTX

Business Wire

2 years ago

RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit

RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting
LCTX

Business Wire

2 years ago

RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q4 2023 Earnings Call Transcript
LCTX

Insider Monkey

2 years ago

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q4 2023 Earnings Call Transcript

Lineage Cell Therapeutics Inc. Reports Q4 and Full Year 2023 Financial Results
LCTX

GuruFocus.com

2 years ago

Lineage Cell Therapeutics Inc. Reports Q4 and Full Year 2023 Financial Results

Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
LCTX

Business Wire

2 years ago

Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 7, 2024
LCTX

Business Wire

2 years ago

Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 7, 2024

Lineage Announces FDA Clearance of IND Amendment for OPC1 Cell Transplant for the Treatment of Spinal Cord Injury
LCTX

Business Wire

2 years ago

Lineage Announces FDA Clearance of IND Amendment for OPC1 Cell Transplant for the Treatment of Spinal Cord Injury

Lineage Cell Therapeutics Announces Closing of $14.0 Million Registered Direct Offering
LCTX

Business Wire

2 years ago

Lineage Cell Therapeutics Announces Closing of $14.0 Million Registered Direct Offering

Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
LCTX

Business Wire

2 years ago

Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering

Tucows Announces Timing for Q4 2023 Financial Results News Release and Management Commentary
LCTX

CNW Group

2 years ago

Tucows Announces Timing for Q4 2023 Financial Results News Release and Management Commentary

LCTX

Associated Press Finance

2 years ago

Camden National: Q4 Earnings Snapshot

CAMDEN NATIONAL CORPORATION REPORTS FOURTH QUARTER AND YEAR END 2023 FINANCIAL RESULTS
LCTX

PR Newswire

2 years ago

CAMDEN NATIONAL CORPORATION REPORTS FOURTH QUARTER AND YEAR END 2023 FINANCIAL RESULTS

Domo Ranked #1 Vendor in Dresner Advisory Services’ Analytical Platforms Report
LCTX

Business Wire

2 years ago

Domo Ranked #1 Vendor in Dresner Advisory Services’ Analytical Platforms Report

Michigan Association of Intermediate School Advisors (MAISA) Selects Varsity Tutors for Schools as Vetted Approved Provider for the 23g MI Kids Back on Track Grant Program
LCTX

Business Wire

2 years ago

Michigan Association of Intermediate School Advisors (MAISA) Selects Varsity Tutors for Schools as Vetted Approved Provider for the 23g MI Kids Back on Track Grant Program

Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024
LCTX

GlobeNewswire

2 years ago

Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024

Share on Social Networks: